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This thesis  describes  the possible  adjuvant  effects of bacterial  DNA, in  the form of  a
DNA vaccine plasmid  (pcDNA3) or oligodeoxyribonucleotides  (ODN), in  the pig. The
effects were assessed mainly as their ability to induce production of immunoregulatory
cytokines. Furthermore, the cells producing type I or type II interferon  (IFN) at various
stimuli were studied.
The plasmid  pcDNA3 was shown to induce  a local production  of IFN-α in  vivo, in
subcutaneous tissue chambers. The in vivo effects of plasmids, expressing the cDNA for
the  cytokines  GM-CSF  or  IL-6,  were  also  tested.  Such  cytokine-expressing  vectors
could have adjuvant effects in DNA vaccines.
The cDNA for porcine  IL-12 (poIL-12) fusion  protein  was cloned  into  pcDNA3. The
plasmid  was  shown  to  express  poIL-12  with  high  in  vitro  biological  activity  in  a
bioassay.  IL-12  and  huIL-18  synergized  in  the  induction  of  IFN-γ  production  in
porcine peripheral  blood  mononuclear  cells (poPBMC), and the IFN-γ producing  cells
were by flow cytometric analyses shown to be T-cells and NK cells.
The antigen-presenting dendritic cells (DC) are important target  cells in vaccination.
Monocyte-derived dendritic cells (moDC) were differentiated from adherent  monocytes
in  the  presence  of  GM-CSF  and  IL-4  in  vitro,  and  were  able  to  produce  different
cytokines  depending  on  stimuli.  IL-12  was  produced  by  the  moDC  mainly  at
stimulation  with  pcDNA3  (preincubated  in  lipofectin),  Actinobacillus
pleuropneumoniae and Sendai virus.  IFN-α was only  produced  in response  to Sendai
virus, and IL-6 and IL-10 mainly in response to A. pleuropneumoniae.
The presence of an unmethylated  CpG dinucleotide  in ODN was essential  for the in
vitro induction of IFN-α in poPBMC. The presence of a poly-guanine  sequence  in the
ends  of  the  ODN  was  shown  to  enhance  its  IFN-α  inducing  capacity.  The  IFN-α
producing  cells in response  to  CpG-ODN,  lipofected  pcDNA3  or  Aujeszky’s  disease
virus  were  by  flow  cytometry  and  in  situ  hybridisation  shown  to  be  a  rare  cell
population,  resembling  the human plasmacytoid  DC,  also  referred  to  as  natural  IFN
producing  cells. The results  show that  certain forms of  bacterial  DNA  have  adjuvant
effects in the pig, which could  be of importance  in the development  of more efficient
vaccines.
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Introduction
Innate and adaptive immunity
The initial immune response generated at the first contact with  antigens  such  as
microorganisms  belong  to  the  non-specific  innate  (natural)  immunity.  This
response is primarily mediated by phagocytic cells, natural killer (NK) cells, and
soluble molecules such as complement  factors,  acute  phase  reactants  and  type  I
interferon  (IFN).  The  phagocytic  cells,  especially  granulocytes  and
monocytes/macrophages,  eliminate  the  microorganisms  by  phagocytosis  and
subsequent degradation. The professional antigen presenting cells  (APC),  that  is
the various types of dendritic cells (DC), are also capable  of  phagocytosis  when
immature, but their main function is to process and present antigens  to  antigen-
specific T lymphocytes, key cells in the adaptive immunity.  In this way, the DC
form  a  bridge between  innate  and  adaptive  immunity.  The  adaptive  immunity
improves  on  repeated  exposure  to  a  given  infection  and  includes  a  specific
immunological memory.  This  ability  to  develop an  immunological  memory  is
utilized  at  vaccination, when the  host  is  immunized  by  a  killed  or  attenuated
living microorganism or its components, in order to evoke specific immunity to
natural infection with the same microorganism.
Cells involved in the innate immune response can, depending on the nature of
the antigen, stimulate specific properties of the adaptive immunity. For instance,
the development of the two major subsets of T-helper (Th) lymphocytes, Th1 and
Th2, can be modulated depending on the cytokines initially produced by DC and
phagocytes (see below). The concept of Th1 and Th2 immunity and its regulation
by DC has primarily been demonstrated in mice and humans, and is not yet firmly
established in pigs. One aim of the present thesis was therefore to study porcine
DC and their ability to produce immunoregulatory cytokines involved in Th1 and
Th2 lymphocyte development.
The role of dendritic cells (DC) in the immune response
The DC  are characterized  by  a  typical  morphology  with  ‘dendritic’  processes,
extremely  active  endocytosis  and  macropinocytosis  and  have  a  high  antigen
processing and presenting capacity  (Mellman &  Steinman,  2001;  Banchereau e t
al., 2000). The immature DC are present in high numbers in many  tissues,  and
lower numbers are also present in blood. They migrate to sites of inflammation,
take up  antigen,  and  maturate upon  inflammatory  signals  to  reach  an  activated
stage with increased ability to present antigen.  Maturation  of  the  DC  occurs  as
they migrate to  lymphoid  organs where  they  activate naïve T  cells  to  antigen-
specific clonal expansion (Sousa et al., 1997; Banchereau et al., 2000; Romani et
al., 2001). The DC is the only type of APC capable of stimulating both naïve and
activated T-cells.  The lymphoid  organs also  contain  many  DC,  that  also  can
capture and present any antigens that may arrive via lymph or blood (Banchereau
et al., 2000).
The  mature  DC  have  reduced  phagocytic  ability,  upregulate  co-stimulatory
molecules (e.g. CD40 and CD80/86) as well as MHC II, and change morphology10
(Banchereau e t  a l . ,  2000;  Hart,  1997).  The  mature  DC  downregulate  the
chemokine receptor 6 (CCR6) that responds to chemokines produced at the site of
inflammation. Instead, they upregulate the CCR7,  and may  therefore respond  to
chemokines produced by cells in the T cell areas  of  secondary  lymphoid  organs
such as lymph nodes and spleen (Kellermann et al., 1999; Dieu et al., 1998).
Exogenous  antigens  can  be  presented  by  DC  on  both  MHC  I  and  MHC  II
molecules. By presentation of exogenous antigen on MHC I molecules, a process
referred to as cross presentation, DC are able to perform a direct activation of CTL
(Cho et al., 2002; Fonteneau et al., 2002; Maurer et al., 2002). In addition, DC
can present glycolipid antigens on CD1 molecules that are recognised by T cells
expressing the γδ T cell receptor (TCR) (Gumperz & Brenner, 2001). Recently, C-
type lectin and lectin-like receptors have been shown to be expressed on the surface
of DC, and can serve as antigen receptors and also regulate migration of DC and
their interaction with T cells (Figdor et al., 2002)
The T cells are activated by the antigen presenting DC when the TCR and CD4
or CD8 of the T cells are interacting with the MHC class I or II in complex with
antigen peptide (Matzinger, 2001; Kalinski et al., 1999). However activation also
requires recognition of co-stimulatory molecules such as CD80/86 (B7) on the DC
by receptors on the T cell  such  as  CD28  and  a  signal  to  T  cells  by  cytokines
produced by especially the DC, for instance IL-12 and IFN-α is also required for
activation  of  the  T  cells  (see  below).  In  the  absence  of  the  appropriate  co-
stimulatory molecules and cytokines, the DC may induce immunological tolerance
by causing anergy or apoptosis in T cells (Mahnke et al., 2002; Shortman & Liu,
2002)
Th1- and Th2-types of immune responses
The Th1-type of immune response is initiated by the production of IL-12 by DC,
and by the ability of DC to stimulate proliferation of naïve T-cells. The latter is
due to production  of  IL-2 by  T  cells  and  the  simultaneous  expression of  high
affinity IL-2 receptor. The presence of IL-12 influences the stimulated Th cells to
Th1 differentiation, including production of IFN-γ (Ma & Trinchieri, 2001). The
Th1  cells,  by  production  of  cytokines  such  as  IFN-γ  and  TNF-β  and  IL-2,
stimulate  cell-mediated  immunity,  including  activation  of  phagocytes,
development  of  cytotoxic  T-lymphocytes  (CTL),  and  also  development  of  B
lymphocytes  producing  opsonizing  and  complement  fixing  antibodies  of  the
immunoglobulin  G  (IgG) isotype.  Furthermore, IL-12 and  IFN-γ  enhances  the
cytotoxity  of  CTL  and  NK  cells.  The  IL-12  production  by  APC  is  in  turn
enhanced by production of IFN-γ by activated Th1 cells (Ma & Trinchieri, 2001).
The expression of the IL-12R on the Th1 cells is maintained  in  the  presence  of
IFN-γ in mice (Szabo et al., 1997). In man, however, type I IFNs (se below) have
this  function,  which  preserves  the  capacity  of  Th1  cells  to  respond  to  IL-12
(Rogge et al., 1997). Th1  responses are also  associated  with  inflammation  and
tissue  injury,  because  TNF-β  and  IFN-γ  recruit  and  activate  inflammatory
leucocytes.11
When DC are not  producing Th1-inducing  cytokines,  they  instead  promote  a
Th2 cell development. The Th2 cells are able to produce cytokines such as IL-3,
IL-4,  IL-5,  IL-6,  IL-10,  IL-13 and  therefore stimulate  development  of  B  cells
producing antibodies  of  the  IgM,  IgA,  IgG,  and  IgE  isotypes  and  furthermore
cause  proliferation  and/or  recruitment  of  tissue  mast  cells  and  eosinophilic
granulocytes.  A  Th2  dominated  immune  reaction  is  present  in  allergies  and
helminth infections. Several cytokines produced by Th2 cells such as IL-4 and IL-
6  and  IL-10  have  anti-inflammatory  actions,  which  inhibit  acute  and  chronic
inflammation by inhibiting pro-inflammatory cytokine production by macrophages
(Abbas et al., 1996).
The  two  sub-types  of  Th  cells  cross-regulate  each  other.  Thus,  the  IFN-γ
produced by Th1 cells inhibits development of Th2 cells, whereas IL-4 and IL-10
produced by Th2 cells block development of Th1 cells (Abbas et al., 1996). It is
therefore possible  to  redirect a  Th2  type  of  immune  response  towards  a  Th1
response by induction of e.g IL-12, or IFN-α production (Biron, 2001; Schopf et
al., 1999; Sinigaglia et al., 1999).
Although there are dissimilarities between porcine and human T cells, there are a
few studies indicating the presence of Th1 and Th2 polarized T cell subsets in the
pig. A Th1-like cytokine profile was detected when peripheral blood mononuclear
cells  (PBMC)  from  immunized  pigs  were  responding  to  the  herpes  virus
Aujeszky’s disease virus ADV in vitro (Fischer et al., 2000). In addition, mRNA
for typical Th2 associated cytokines were found in liver and intestinal tissue from
pigs infected with the parasite Schistosoma japonicum (Oswald et al.,  2001).  A
typical  Th1  type  of  immune  response  in  the  pig  was  observed  after  oral
immunization with cholera toxin, which resulted in cholera toxin-specific delayed
type hypersensitivity responses that associated with increased secretion  of  IFN-γ
(Foss & Murtaugh, 1999). Furthermore, a  vaccine  against  ADV  induced  a  Th1
type of immune response, as indicated by the induction of antigen-specfic IFN-γ
producing cells (Zuckermann et al., 1998). Recently,  Laval et  al  showed that  a
DNA vaccine against ADV induced IFN-γ production  in  antigen  specific CD8+
CTL (Laval et al., 2002).
Pathogen Recognition Receptors
The  cells  of  the  innate  immune  system  contain  a  set  of  molecular  pattern
recognition  receptors  (PRR)  that  recognize  certain  structures  termed  pathogen
associated molecular patterns (PAMP), present on pathogens but normally not in
healthy tissue. Activation of the PRR  generate the first signals  that  indicate the
presence  of  infection  (or  danger)  to  DC  and  other cells  of  the  innate  immune
responses.  The  cells  contain  several  different  receptors  that  have  affinity  to
different general structures on pathogens, e.g. the Toll-like receptors (TLR) (Ozato
et  al.,  2002;  Medzhitov,  2001),  scavenger  receptors  (Peiser et al.,  2002),  and
lectin  receptors  such  as  the  mannose-receptor  (Stahl  &  Ezekowitz,  1998).  For
instance,  the  TLR  family  has  ten  members (TLR1-10),  that  recognize  distinct
microbial components and they also recognize endogenous ligands induced during
the  inflammatory  response.  Examples  of  ligands  for  TLRs  are  bacterial
lipoproteins,  which  are  recognized  by  TLR1,  TLR2,  TLR4  and  TLR6,12
lipopolysaccharides  and  heat  shock  protein  60  by  TLR4,  flagellin  by  TLR5,
dsRNA by  TLR3,  imidazoquinolin  (e.g.  imiquimod)  by  TLR7  and  TLR8  and
unmethylated CpG-DNA is recognized by TLR9.
The TLRs triggers different signalling pathways in the cell, leading to different
biological responses by the various stimuli (Ozato et al., 2002; Medzhitov, 2001).
Especially prominent is the production of cytokines associated with inflammatory
responses such as  IL-1,  IL-2,  IL-6,  IL-10,  IL-12,  IL-15,  TNF-α, GM-CSF  and
IFN. To our knowledge there are no reports on the presence of TLRs in the pig,
but the cDNA for bovine TLR2 and TLR4 and chicken TLR2 have  been  cloned
(Werling &  Jungi,  2003).  However,  because  the  TLRs  are highly  evolutionary
conserved,  they  are  most  likely  also  present  in  the  pig  and  have  the  same
important role in the immune response as in humans and mice.
Subsets of dendritic cells
The capacity  of  DC  to  stimulate  T  lymphocytes  is  linked  to  their  stage  of
differentiation  (immature  vs.  mature)  and  activated  production  of  cytokines.
Furthermore, there are several different subsets of DC that differ in specific surface
markers  and  functional  capacity  depending  on  lineage,  origin  and  stage  of
maturation  The biology  of  DC  has  been  extensively  studied  in  man  and  mice
(Banchereau e t  a l . ,  2000;  Shortman  &  Liu,  2002),  and  the  classification  of
dendritic cell subsets in mice and man differs (Shortman & Liu, 2002).
DC  populations  originate  from  CD34
+  hemopoetic  stem  cells  in  the  bone
marrow that develop into immature DC.  The human  immature  DC  lack  typical
lineage-specific  markers  and  are divided  into  CD4+CD11c+  myeloid  DC,  and
CD4+CD11c- immature plasmacytoid DC (PDC) (Kadowaki & Liu,  2002).  The
immature myeloid DC express myeloid surface markers, they undergo spontaneous
maturation in culture and may induce allogeneic T cell proliferation. The immature
plasmacytoid  DC  has  plasmacytoid  morphology  and  is  dependent  on  IL-3  for
survival and differentiation in culture. Based on the ability  to  secrete IL-12 and
thereby preferentially induce a Th1 type of immune response the human myeloid
DC has been referred to as DC1, whereas human plasmacytoid DC was designated
DC2 (Kadowaki & Liu, 2002; Liu et al., 2001; Grage-Griebenow et al., 2001). In
the mouse, lymphoid DC, also referred to as DC2, directs the immune  response
towards a  Th1  type  by  their  high  IL-12 producing capacity  (Shortman  &  Liu,
2002). The different DC subsets are also named according to their localization, in
humans for instance epidermal Langerhans  cells,  dermal interstitial  DC,  splenic
marginal zone DC, T-zone interdigitating cells, germinal center DC,  thymic DC,
liver DC and blood DC (Banchereau et al., 2000; Shortman & Liu, 2002).
Myeloid DC
Myeloid DC precursors can be transported via the blood into tissues  where  they
become resident immature DC. These cells, in skin, are referred to as Langerhans
cells. Alternatively, the precursors remain circulating in the blood  until  attracted
by  chemokines  to  a  site  of  inflammation.  Then  they  may  migrate  through
endothelium and  differentiate  into  immature  myeloid  DC.  Myeloid  DC  can  be
generated in vitro from bone marrow and from monocytes. The presence of GM-13
CSF alone, or in combination with IL-4, differentiated murine bone marrow cells
into DC (Hart, 1997). Immature myeloid DC have also been generated in vitro by
differentiation of  blood  monocytes  in  the  presence  of  GM-CSF  and  IL-4.  The
presence of LPS, TNF-α, IL-1, IFN-α or necrotic cells induce maturation of such
immature myeloid DC (Shortman & Liu, 2002; Luft et al., 2002). These agents
were  used  to  mimic  the  signals  to  which  the  DC  are  exposed  in  vivo  during
inflammation. The myeloid DC express several TLR, especially TLR2, 3, 4, 5, 7
and 8 (Kadowaki & Liu, 2002; Krug et al., 2001b).  These  and  other PRR,  are
involved  in  the  recognition of  for instance microbial  constituents  and  activate
maturation and cytokine production in the DC.
Plasmacytoid DC
The  immature  plasmacytoid  DC  are  characterised  by  high  IFN-α  producing
capacity (Fitzgerald-Bocarsly, 2002; Cella et al., 1999; Kadowaki &  Liu,  2002)
and at least a major part of them constitute the ‘natural IFN-α/β producing cells’
(NIPC; see below).  They can  be  identified  by  their  selective  expression  of  the
markers blood  dendritic cell  antigen  (BDCA)  2  and  4  (Dzionek et al.,  2002).
These PDC express TLR7 and TLR9 (Hornung et al., 2002; Krug et al., 2001b).
Recently,  oligodeoxyribonucleotides  containing  cytidine-phosphate-guanine
dinucleotides (CpG-ODN; see below), a TLR9 ligand, and imiquimod,  a ligand
for TLR7, were shown to induce IFN-α  production  and  to  cause  maturation  of
PDC (Bauer et al.,  2001a;  Bauer et al.,  1999;  Krug et al.,  2001b;  Ito e t  al.,
2002). The IFN-α can in turn cause maturation of immature myeloid DC (Gursel
et al., 2002). Although characterized by extremely high IFN-α producing ability,
the PDC can also produce high amounts of IL-12 when stimulated by CpG-ODN
in combination with ligation of CD40 (Krug et al., 2001b). Recently,  a  murine
NIPC/PDC  was  described  (Shortman  &  Liu,  2002).  That  the  myeloid  and
plasmacytoid  DC  express  different  sets  of  TLRs,  may  explain  why  these  DC
respond  differentially  to  microbial  stimuli,  the  NIPC/PDC  preferentially  being
activated by CpG-DNA, and  the  myeloid  DC  by  several  microbial  components
and dsRNA.
Porcine DC
In  the  pig,  DC  has  been  isolated  from  thymus  (Salmon e t  a l . ,  2000),  skin
(Bautista et al., 2002; Vana & Meingassner, 2000), spleen (Chun et al.,  1999),
Peyers patches (Makala et al., 1998) and jejunal lamina propria (Haverson et al.,
2000).  Porcine DC  have  also  been  generated  in  vitro  from  bone  marrow  cells
(West et al., 1999; Carrasco et al., 2001) and from blood monocytes (Carrasco et
al., 2001; Paillot et al., 2001). The latter papers describe the generation of porcine
monocyte-derived  DC  (moDC)  using  porcine  (po)GM-CSF  and  poIL-4  for
differentiation.  In  that  system,  presence  of  TGF-β1,  TNF  or  LPS  during
differentiation altered the cell morphology and increased their ability to stimulate
an allogeneic MLR (Carrasco et al., 2001; Paillot et al., 2001). The bone marrow
derived DC (bmDC) and the moDC expressed the myeloid marker SWC3, MHC
class II, CD1 and CD80/86. The DC also expressed CD14 and CD16, before and
after maturation (Carrasco et al., 2001). Conversely, a marked down regulation of
CD14 during differentiation of monocytes to DC  was  observed  by  Paillot  et  al14
(Paillot et al., 2001). In their study, the moDC were shown to also express  the
integrins  CD11a,  CD18,  CD11b/c,  as  well  as  CD36,  CD68  and  p55  facsin
(Paillot et al., 2001).  The presence  of  transforming  growth  factor  β1  (TGF-β1)
together with IL-4 and GM-CSF induced the  porcine monocytes  to  differentiate
into  Langerhans  cells.  Furthermore,  an  IFN-α  producing  cell,  resembling  the
NIPC/PDC has been demonstrated (see below).
The immunoregulatory cytokines IL-12 and IL-18
Due to the essential role of IL-12 in the regulation and maintenance of a Th1 type
of immune response, IL-12 could be an important  adjuvant  in  vaccines.  Human
IL-12  (huIL-12)  was  first  known  as  NK  cell  stimulatory  factor  or  cytotoxic
lymphocyte  maturating  factor.  The bioactive  form  of  IL-12  is  a  heterodimeric
protein of 70 kDa, which consists of a 35 (p35) and a 40 (p40) kDa subunit. Co-
expression of  the  two  subunits  of  IL-12  is  required  for  generation  of  active
cytokine. Furthermore, a homodimeric form of p40 may act as an IL-12 receptor
antagonist (Ma & Trinchieri, 2001).
The poIL-12 was cloned,  and  the  amino  acid  sequences  of  the  p35  and  p40
subunits  showed  approximately  85%  homology  compared  to  the  human
counterparts  (Foss  &  Murtaugh,  1997).  A  recombinant  heterodimeric  bioactive
porcine  IL-12  was  produced  by  expression  of  the  cDNA  for  the  p35  and  p40
subunits using a monocistronic baculovirus as vector  (Kokuho et al.,  1999).  In
vivo  effects of  the  poIL-12,  such  as  increased IgA titers  in  mucus,  were  also
shown in an oral immunization model (Foss et al., 1999). Differential expression
of  mRNA  in  various  porcine  tissues  indicates  that  the  poIL-12  subunits  are
regulated independently (Foss & Murtaugh, 1997). The p35 subunit in mice was
constitutively  expressed  in  several  tissues  (Bost  &  Clements,  1995),  but  the
expression is regulated in certain cell types (Vaidyanathan et al., 2001).
Interleukin-18 (IL-18), first known as interferon-γ inducing factor (Okamura e t
al., 1995), has structural homology to IL-1β, and both the human and porcine IL-
18  is  produced  in  an  inactive  precursor  form  which  is  processed  by  IL-1β
converting enzyme  to  its  active form (Muneta et al.,  2000b;  Gu e t  al.,  1997;
Fonteneau et al.,  2002).  The  poIL-18  has  been  cloned  and  showed  an  81%
homology to the human  amino  acid sequence  (Muneta et al.,  1999).  Recently,
also the IL-18 receptor has been cloned (Muneta et al., 2002). The production of
IL-18, can be induced by the interaction between human Th1 cells and APC in the
presence of antigen and also occurs in activated human and porcine macrophages
(Kohno & Kurimoto, 1998; Foss et al., 2001). In the pig, poIL-18 was detected
in  plasma  and  bronchoalveolar  lavage  fluid  at  experimental  infection  with
Actinobacillus  pleuropneumoniae  (Muneta e t  a l . ,  2000a).  Constitutive  and
induced expression of  IL-18 mRNA  was detected in  various  tissues,  including
lymphoid  organs of  the  intestinal  mucosa (Muneta et al.,  2000a;  Foss e t  al.,
2001; Fournout et al., 2000).
IL-18 resembles IL-12 in the ability to induce production of IFN-γ by NK cells
and T-cells, and to increase NK cell cytotoxity (Tominaga et al., 2000; Nakanishi
et  al.,  2001).  The  differentiation  of  CD4
+  T-cell  into  Th1  cells  by  IL-12  is15
promoted by the presence of  IL-18, and  IL-18  may  also  induce  proliferation  of
activated Th1 cells without help from IL-12 (Tominaga et al.,  2000;  Kohno  &
Kurimoto, 1998; Kohno et al.,  1997;  Okamura et al.,  1998).  IL-12 and  IL-18
synergize to stimulate IFN-γ production from human and murine Th1 cells.
IFN-γ γ γ γ     (Type II IFN)
IFN-γ is a central immunoregulatory cytokine that promotes and mediates a Th1
type of immune response (Abbas et al.,  1996).  The IFN-γ  binds  to  the  IFN-γ
receptor (IFN-γR) and activates the STAT 1 signal transduction pathway, resulting
in expression of multiple genes. In this way it influences the immune system in
many  ways.  It  enhances  production  of  IL-12  by  macrophages  and  DC,  and
stimulates the microbicidal effects of macrophages. IFN-γ upregulates MHC class
I and II molecules and thereby enhances antigen presentation for both Th and CTL.
It suppresses Th2 cell development and promotes Th1-type of Ig class switching
in B cells.
Work in mice and man have identified Th1 cells, CD8 positive T cells and NK
cells  as  the  major  IFN-γ  producers,  but  other  cells  such  as  B  cells  and
macrophages  have  also  been  described  as  producers  (Okamura e t  a l . ,  1998;
Tominaga et al., 2000; Nakanishi et al., 2001; Otani et al., 1999). As described
in the previous section, IL-12 especially in  combination  with  IL-18  is  a  potent
inducer  of  IFN-γ,  and  production  of  IFN-γ,  at  least  by  T  cells,  may  require
interaction with DC and upregulation of the IL-12R.
Little is known concerning the identity of the IFN-γ producers in the pig, and
their activation by e.g. IL-12/IL-18. The proportion of porcine PBMC  producing
IFN-γ after polyclonal activation by phorbol myristic acid and calcium ionophore
A23187  was shown  to  be  significantly  higher in  adult  than  in  young  animals
(Rodriguez-Carreno et al., 2002). The subpopulations of T lymphocytes producing
IFN-γ were mainly αβ T cells. In young pigs, also  a  high  proportion  of γδ T
cells  produced  IFN-γ.  In  adult  animals,  T  cells  double  positive  for  CD4  and
CD8α and also CD4-positive/CD45RA-negative cells, including memory T cells
(Saalmuller et al.,  2002),  produced  IFN-γ.  The  IFN-γ  production  by  PBMC
derived from pigs immunized by a DNA vaccine against ADV and restimulated in
vitro  by  antigen  loaded  autologous  DC  mainly  resided  in  T  cells  with  high
expression of CD8α, that is CD8 positive CTL (Laval et al., 2002).
Type I interferons
Type I IFN genes
The ability of IFN to protect cells from viral infection was first described in 1957
(Isaacs & Lindenmann, 1957). They discovered a soluble factor, produced by cells
exposed to inactivated influenza virus that  protected  cells  against  infection with
live influenza virus. The term  interferon  originally  comes from  this  interference
with viral replication. Today,  it  is  known  that  the  IFN  are products  of  several
different genes and can be divided into type I IFN and type II IFN. Type I IFN are
further divided into six subfamilies (IFN-α, -β, -δ, -τ, -ω, and -κ) while only one
type II IFN member has been described (IFN-γ). In man, 13 nonallelic genes for16
different IFN-α subtypes and four pseudogenes have been described (Diaz & Testa,
1996).  In  the  pig,  there  are  about  12  genes  for  IFN-α  subtypes  located  on
chromosome  1  (La  Bonnardiere et al.,  1994).  Only  one  IFN-β  gene  has  been
described in man (Diaz & Testa, 1996) and in the pig  (Artursson et al.,  1992).
There are at least three functional IFN-ω genes in pig, but only one is present in
man (La Bonnardiere et al., 1994; Diaz & Testa, 1996). A new human IFN, the
IFN-κ,  was  recently  identified  and  was  found  to  be  produced  by  keratinocytes
(LaFleur et al., 2001). This IFN has not been identified in pigs. The IFN-δ and
IFN-τ  are constitutively  expressed  in  trophoblast  cells  of  pigs  and  ruminants,
respectively (Lefevre et al., 1998; Alexenko et al., 2000). The IFN-δ has  so  far
only  been  described  in  pigs  (Lefevre e t  a l . ,  1998).  IFN-τ  is  present  during
pregnancy in ruminants and is important for the implantation and early embryonic
development (Alexenko et al., 2000) and  is  not  inducible  by  virus.  IFN-γ  and
perhaps IFN-δ may have the same effect in the pig (La Bonnardiere et al., 2002).
Effects of type I IFN
There  is  one  common  receptor  for  the  type  I  IFN  that  is  termed  IFNAR  and
consists of two subunits, the IFNAR-1 and IFNAR-2. Activation of the  IFNAR
leads to subsequent signalling into the cell via the Janus protein tyrosine  kinase
(Jak)-STAT signal transduction pathway (Taniguchi & Takaoka, 2001; Taniguchi
& Takaoka, 2002). Activation of the receptor leads to tyrosine phosphorylation of
STAT1  and  STAT2.  The activated  STATs  together  with  interferon  regulatory
factor 9  (IRF9),  form  a  transcriptional activation  complex,  the  IFN-stimulated
gene factor 3 (ISGF3). Furthermore a STAT1 homodimer is formed. Both ISGF3
and the STAT1 homodimer translocate to the nucleus and activate expression of a
large number of genes, the products of which mediate the many effects of type I
IFNs outlined below (Schlaak et al., 2002; Der et al., 1998). The type I IFN are
produced in response to e.g. virus infections (see below), and cause inhibition of
virus  replication  at  several  stages.  For  example  viral  penetration,  uncoating  of
virions,  transcription,  translation  or  the  assembly  of  progeny  virus  may  be
affected. There are several molecular systems described that are activated by type I
IFN and in various ways interfere with viral replication (Stark et al., 1998). They
include the enzyme 2’-5’ oligoadenylate synthetase in the 2’-5’A system, dsRNA
dependent protein kinase (PKR)  and  the  Mx  protein.  Furthermore,  type  I  IFNs
induce apoptosis of cells infected by virus.
Apart from the antiviral effects, the type I IFNs may also  have other effects on
cells. These effects may differ depending on cell type, and can for instance be anti-
proliferative, cytotoxic,  or  anti-tumoral  (Belardelli  &  Ferrantini,  2002;  Biron,
1999; Stark et al., 1998).
Type IFNs also exert a large number of immunoregulatory effects and especially
IFN-α may be a key cytokine not only in the innate immune system but also in
adaptive immune responses (Biron, 1999; Biron,  2001;  Belardelli  &  Ferrantini,
2002;  Bogdan,  2000;  Akbar et al.,  2000).  IFN-α  has  maturing  effects on  the
immature myeloid DC, enhancing their ability to present antigen to and activate T
cells (Santini et al., 2000; Luft et al., 2002; Le Bon & Tough, 2002; Gallucci et
al.,  1999).  Type  I  IFNs  also  increase  the  activity  of  CTL  by  inducing  up-17
regulation of MHC class I on virus infected cells, and increase the cytotoxic effects
of NK-cells. Furthermore, type I IFNs also increases the numbers of Fc-receptors
on macrophages, enhancing their phagocytic activity.
The type I IFN, especially IFN-α, can have an important role in the regulation
of the Th1 or Th2 types of immune responses. As described above,  IFN-α  may
promote a development of a Th1 type of immune response by up-regulation  and
maintenance  of  a  functional  IL-12  receptor  on  Th  cells  in  man  (Rogge et al.,
1998). Type I IFN in mice was a potent enhancer of the primary antibody response
to the antigen chicken gammaglobulin, with both long-lasting antibody responses
and development of memory (Le Bon et al., 2001). The type I IFN was in  this
respect comparable to Freund’s complete adjuvant (CFA). This adjuvant effect of
IFN could be mediated by DC (Le Bon & Tough, 2002). Furthermore, some  of
the adjuvant effects of CpG-ODN in vivo in mice, especially in priming of antigen
specific CTL, have recently been shown to be dependent on the effects of IFN-α
on DC (Cho et al., 2002). Type I IFN can also stimulate differentiation of T cells
and inhibit apoptosis associated with activation, as well as promote proliferation
of  memory  CTL  and  maintain  immunological  memory  (Akbar e t  a l . ,  2000;
Sinigaglia et al., 1999; Marrack et al., 1999). In addition, type I IFN can promote
survival  and  differentiation  of  B  cells  and  enhance  B  cell  receptor-dependent
responses (Braun et al., 2002; Ruuth e t  al.,  2001).  Obviously,  other cytokines
such as IL-12 and IL-15 can be further involved, and IL-15 can actually be induced
by IFN-α (Mattei et al., 2001; Zhang et al., 1998).
Induction of type I IFN production
The genes  for the  type  I  IFN  have  common  regulatory  sequences  and  may  be
induced in many different cell-types, mainly as a response to virus infection. The
expression of IFN-α/β genes is induced by transcription factors  for  the  IFN-α/β
genes that include several members of the IRF family. Of the 9 members of  the
IRF family of proteins, the IRF-3, -5 and -7 are important for induction of high
levels  of  IFN-α/β (Taniguchi  &  Takaoka,  2002;  Barnes e t  a l . ,  2002).  These
proteins are present in the cytoplasm of uninfected cells, but translocate into  the
nucleus at viral infection. Type I  IFN  can  upregulate  expression  of  for  instance
IRF-1, and IRF-7 (Taniguchi & Takaoka, 2002; Taniguchi & Takaoka, 2001). In
this  way,  type  I  IFN  upregulates  its  own  synthesis,  a  phenomenon  termed
priming. Also other cytokines  such  as  GM-CSF  and  IL-3 have  priming  effects
(Cederblad & Alm, 1991). The different  IFN-α  genes  are  expressed  at  different
levels in different cell types and this may be due to differences in expression of the
relevant IRFs (Barnes et al., 2002).
Many different microorganisms can trigger production  of  type  I  IFN  in  cells,
including viruses, bacteria, parasites, nucleic acids such  as  dsDNA  and  dsRNA,
short  ODNs  (see  below)  and  also  certain  chemicals,  such  as  imiquimod
(Fitzgerald-Bocarsly, 2002). The pathways they utilize to induce and activate the
essential transcription factors (see above) involved in IFN-α/β gene expression is
however incompletely known.18
With respect to viruses, viral glycoproteins seem to be important for induction of
type I IFN by certain viruses (Ankel et al., 1998; Baudoux et al., 1998; Charley
et al., 1991; Zeng et al., 2002). It has been argued that viral nucleic acid is not
required for this  induction.  However,  RNA-  and  DNA-containing  products  of
necrotic or apoptotic cells when combined with antibodies or lipofectin can trigger
IFN-α  production  in  NIPC/PDC  (Båve e t  a l . ,  2001  ;  Lövgren  et  al, t o  b e
published). In fact, double stranded RNA (dsRNA), which is  produced  by  most
viruses at some point during their replication cycle is the classical inducer of type
I  IFN  production  (Stark et al.,  1998).  The  Toll-like  receptors  have  a  special
relation  to  IFN-α/β  induction  (see  below),  because  the  IFN-α/β  production
induced  by  ODNs  requires  TLR9,  while  induction  by  dsRNA  and  imiquimod
requires TLR3 and TLR7, respectively (Ozato et al., 2002).
Induction  of  IFN-α  by  bacteria,  or  components  of  bacteria  such  as
lipopolysaccharide  (LPS)  and  bacterial  DNA  has  also  been  described  (Bogdan,
2000).  In  the  pig,  low  levels  of  IFN-α  were  induced  by  heat  inactivated  A.
pleuropneumonae in  cultures of  PBMC  (Wattrang et al.,  1998),  approximately
100-fold lower than the levels of IFN-α induced by ADV. The ability of bacteria
to induce IFN-α production may in part be due to the presence of CpG-DNA (see
below).
IFN-α producing cells
In humans, infrequent cells referred to as NIPC/PDC have been shown to produce
high amounts of IFN-α, as discussed above (Fitzgerald-Bocarsly, 2002; Kadowaki
& Liu, 2002). The NIPC/PDC produce IFN-α upon stimulation by a wide variety
of bacteria and viruses, including CpG-DNA, while IFN-α production by myeloid
DC and monocytes can only be triggered by a limited number of stimulators, such
as Sendai virus or dsRNA (Fitzgerald-Bocarsly, 2002; Rothenfusser et al., 2002).
When porcine PBMC were stimulated by the transmissible gasteroenteritis virus
(TGEV) or ADV in vitro, only approximately 0.01% of the cells produced  IFN-
α, but  with  a  high  quantity  of  IFN-α  per  cell  (Nowacki  &  Charley,  1993;
Nowacki et al., 1993; Artursson et al., 1992). The frequenαcy of IPC  increased
with  the  age  of  the  animals  tested  (Nowacki et al.,  1993).  These  IPCs  might
constitute a porcine counterpart to the human NIPC/PDC and were shown  to  be
non-adherent cells expressing swine leukocyte antigen (SLA) class II antigens and
CD4, but not CD2, CD8 or a B cell marker (Charley & Lavenant, 1990; Nowacki
& Charley, 1993). The SLA class II expression was upregulated at stimulation by
virus. A population of IPC  was also  detected in  porcine intestinal  mucosa and
spleen of TGEV infected animals (Riffault et al., 1997; Riffault et al., 2001). The
expression of SWC3 was not found in the IPC detected in the gut, but some of
the  IPC  detected in  the  spleen were SWC3  positive  in  pigs  after  intravenous
injection with TGEV (Riffault et al., 1997). The porcine IPC were found mainly
in the mesenteric lymph nodes close to virus-infected cells, but the IPC appeared
not to be infected (Riffault et al., 2001). Also after intradermal administration of
Aujeszky’s disease virus (ADV) infected cells, the IPC were mainly detected in the
regional lymph  nodes  (Artursson et al.,  1995).  Large quantities  of  IFN-α a r e
therefore produced in the lymphoid organs, and the influence of this IFN-α on the19
initiation and development of a specific immune  response  in  the  pig  should  be
profound and merits further study.
Immunostimulatory CpG-DNA
As mentioned before, DNA that contains unmethylated CpG dinucleotides (CpG)
stimulates  the  innate  immune  system  of  vertebrates  and  has  been  termed
immunostimulatory  DNA.  Unmethylated  CpGs  are  present  at  the  expected
frequency in bacterial DNA, but are decreased in number and also often methylated
in vertebrate DNA (Bird, 1980). Immunostimulatory DNA was originally shown
to be an important adjuvant component of the Bacillus Calmette Guerin. Purified
bacterial DNA was shown to induce IFN-α  production  by  PBMC,  increase  NK
cell  activity  and  to  stimulate  B-cell  proliferation  and  antibody  production
(Yamamoto e t  a l . ,  2002).  Oligodeoxyribonucleotides  containing  unmethylated
CpG  (CpG-ODN)  were  shown  to  mimic  these  immunostimulatory  effects  of
bacterial DNA (Krieg & Davis, 2001), and promote  antigen-specific  cellular  and
antibody  responses.  The  immunostimulatory  effect  of  CpG-ODN  are  now
evaluated  as  an  adjuvant  in  vaccines  and  also  for  the  treatment  of  cancer  and
allergies (Krieg, 2001; Krieg & Davis, 2001).
The  immunostimulatory  capacity  of  CpG-ODNs  appears  dependent  on  the
presence of TLR9 on the target cells, in humans NIPC/PDC and B cells (Hornung
et  al.,  2002;  Kadowaki  &  Liu,  2002).  In  humans,  CpG-DNA  stimulates
NIPC/PDC to upregulate co-stimulatory molecules and to produce e.g. IL-12 and
IFN-α. The B cells are also directly stimulated to  proliferation and  to  antibody
production.  The  activated  NIPC/PDC  can  promote  a  Th1-type  of  immune
response.  Furthermore,  the  cytokines  produced  by  NIPC/PDC  can  cause
maturation  of  other types  of  DC,  for  instance moDC,  that  also  can  drive  the
development of Th1 cells and CTL. These cytokines can obviously also stimulate
the immune system in many other ways, as described above.  In  porcine  PBMC
(poPBMC), CpG-ODN induced production of IL-6, IL-12 and TNF-α (Kamstrup
et  al.,  2001)  and  the  unmethylated  CpG-containing  vaccine  plasmid  pcDNA3
caused production of IFN-α and IL-6 (Johansson et al., 2001; Magnusson et al.,
2001a). The target cells for the CpG-DNA were however not determined.
CpG-ODNs  are  considered  to  activate  TLR9  via  a  process  involving  initial
receptor mediated endocytosis via scavenger receptors, which is CpG-independent.
TLR9  is  present in  endosomes,  where  it  may  interact with  CpG-DNA,  and  is
dependent on endosomal acidification (Wagner, 2002; Ahmad-Nejad et al., 2002;
Bauer & Wagner, 2002; Häcker et al., 1998). The activation of the TLR9 requires
an unmethylated CpG (Bauer et al., 1999; Bauer et al., 2001b; Bauer & Wagner,
2002; Ozato et al., 2002; Hemmi et al., 2000), as detailed below. The structure
and  function  of  the  TLR9  and  the  signal  transduction  pathways  involved  in
cytokine gene expression  have  recently  been  reviewed  (Bauer  &  Wagner,  2002;
Wagner, 2002).
The importance of the CpG motifs for the  immunostimulatory  effect of  DNA
has been studied in man, mice and primates (Krieg, 2002a) and  recently  also  in
farm animals, dogs and cats (Brown et al., 1998; Rankin et al., 2002; Rankin et20
al.,  2001).  The optimal  motif  varies between  species,  but  a  general  consensus
motif of XCGY where X  is  any  base  but  C  and  Y  is  any  base  but  G  (Krieg,
2002a) has been suggested. In general, an increase in the  number of  CpG  in  an
ODN enhanced the immunostimulatory activity. However, the addition of CpG in
the end of an ODN or in an unfavourable sequence context reduced the degree of
cell  activation.  Elimination  of  CpG  dinucleotides  from  ODN  abolished  their
stimulatory activities, as did methylation of the cytosine in the CpG.
The immunostimulatory  capacity  of  ODN  is  also  affected  by  the  chemical
structure  of  the  ODN  backbone.  ODNs  can  be  made  more  resistant  against
nucleases by the use of  a  complete  phosphorothioate backbone  (Agrawal et al.,
1995; Zhao et al., 1993), or phosphorothioate nucleotides at the 5’ and 3’end and
central  phosphodiester  nucleotides  (thioate/diester  ODN)  (Krieg,  2002b).  In
general,  ODNs  containing  phosphorothioate  nucleotides  are  more  potent  at
activating B-cells compared to the same sequence with a phosphodiester backbone
(Krieg, 2002a). In contrast, thioate/diester ODNs were superior to other ODNs in
their induction of IFN-α in plasmacytoid DC (Jarrossay et al., 2001; Krug et al.,
2001a) and in activation of NK cells (Ballas et al., 1996).
The  thioate/diester  ODNs  mentioned  above  contained  consecutive  guanines
(poly-G  sequences)  in  the  ends.  Such  poly-G  sequences  can  also  enhance  the
uptake of ODNs by the cells  (Kadowaki  &  Liu, 2002;  Kadowaki et al.,  2001;
Jarrossay et al., 2001; Hemmi et al., 2000; Hemmi et al., 2002). In fact, in most
studies ODNs lacking poly-G sequences were extremely poor  inducers  of  IFN-α
production. However, they were strong inducers when combined  with  lipofectin.
The lipofectin forms cationic liposomes with nucleic acids and protects them from
degradation  by  nucleases  (Thierry  &  Dritschilo,  1992),  and  perhaps  more
importantly increases their uptake by cells (Pisetsky  &  Reich,  1999;  Thierry &
Dritschilo, 1992; Bennett et al., 1992; Hartmann et al., 1998). Also the plasmid
pcDNA3 induced high levels of IFN-α in porcine PBMC  in vitro, but only when
lipofected  (Johansson e t  a l . ,  2001;  Magnusson e t  a l . ,  2001a).  In  human
NIPC/PDC,  the  IFN-α  production  induced by  pcDNA3  was  dependent  on  the
presence of anti-DNA antibodies, that probably acted by increasing the uptake of
the plasmid in the same way as lipofectin (Vallin et al., 1999).
DNA vaccines
Vaccines consisting of DNA plasmids expressing the cDNA for specific antigens
can induce protection against infectious agents in humans, mice and farm animals
(Babiuk,  2002;  Babiuk e t  al.,  2000;  Gurunathan et al.,  2000a).  Compared  to
DNA  vaccines,  traditional  vaccines  based  on  killed  or  attenuated  organisms  as
immunogen  may  have  limitations,  including  poor  CTL  mediated  immunity,
reversion  to  virulence,  spread  of  the  organisms  and  pathogenesis  in  immuno-
compromised animals (Murtaugh & Foss,  2002). One important feature of  DNA
vaccines is their ability to mediate antigen presentation on both MHC class I and
MHC class II molecules. When vaccine plasmids transfect host cells, the protein
antigen is expressed,  processed and  presented in  association  with  MHC  class  I
molecules and in this way mimic natural infection with intracellularly replicating
pathogens. Furthermore, if the antigen is released from transfected  cells,  both  B21
cells  and  Th  cells  may  be  stimulated  via  MHC  class  II  restricted  antigen
presentation by DC, that have taken up the antigen. It is also possible that the DC
become directly transfected, and DC have the ability to  present antigen on  both
MHC class I and II (Gurunathan et al., 2000a; Cho et al., 2002). Thus, different
mechanisms have been suggested for the generation of immune responses by DNA
vaccines, either by direct transfection of DC, or by the transfer of antigen from e.g.
transfected myoblasts to  DC,  as  free antigen  released by  transfected cells  or  as
apoptotic transfected cells  (Gurunathan et al.,  2000a;  Albert et al.,  1998).  The
presentation of antigen by MHC class I and II molecules thus promotes both CTL
and Th cell development. It is well known that the way of delivery, the amount of
antigen, and if the encoded antigen is secreted or not,  have effects on the type of
immune response generated (Liu & Ulmer, 2000; Gurunathan et al., 2000a; Ulmer
& Liu, 2002). It has also been demonstrated that co-delivery of the vaccine vector
pcDNA3 encoding a HIV antigen with a plasmid encoding Fas, a gene involved in
the induction of apoptosis, promoted the infiltration of DC to the site of injection
(Chattergoon et al., 2000). In this way the delivery of plasmid encoded antigen to
the antigen-presenting DC could be facilitated.
It  is  to  be  expected  that  new  approaches  will  improve  on  the  results  so  far
obtained with DNA vaccines, for instance the often-low antibody  responses.  For
this purpose, the combination of a primary immunization by a DNA vaccine with
recombinant protein  as  booster  immunization  can  induce  stronger  cellular  and
humoral  immunity  and  more  complete  protection  (Liu  &  Ulmer,  2000;
Gurunathan et al., 2000a). In accordance, multiple injections of plasmid followed
by a boost  of  plasmid  plus  human  immunodeficiency virus  (HIV) Env  protein
induced a  strong  CTL  response and  increased neutralizing  antibody  activity  in
rhesus monkeys, as well as protection against challenge (Letvin et al., 1997; Baig
et al., 2002).
CpG-DNA and cytokines as adjuvant in DNA vaccines
It has been shown that plasmid vectors could have adjuvant activities themselves
through the presence of CpG dinucletides (Gurunathan et al., 2000a; Klinman et
al., 2000; Sato e t  al.,  1996).  Also  the  number of  CpG  motifs  may  affect the
adjuvant activity DNA  vaccines  (Gurunathan et al.,  2000a;  Krieg et al.,  1998;
Cohen et al., 1998). In fact, addition of CpG motifs enhanced both cell-mediated
and humoral immunity to a DNA vaccine against HIV (Kojima et al., 2002), and
the response was dependent  on  the  number of  CpG  motifs  included.  Also,  the
cellular  immune  response  to  a  DNA  vaccine  against  bovine  herpesvirus  was
correlated to the CpG content in the plasmid vector (Pontarollo et al., 2002a). In
the pig, the adjuvant capacity of an unmethylated CpG-containing vaccine plasmid
pcDNA3 was shown by induction of high levels of IFN-α in vitro (Johansson et
al., 2001). Furthermore, methylation of the cytosine in the CpGs of the pcDNA3
plasmid abolished the  IFN-α  inducing  activity  (Magnusson et al.,  2001a),  but
exchange of the CpG motif-containing ampicillin resistance gene to a kanamycin
resistance gene (lacking CpG motifs) did not affect the amounts of IFN-α induced
by pcDNA3, which therefore may be due to the presence of the many other CpG
motifs in other parts of the plasmid.22
The  importance  of  CpG-induced  cytokines  such  as  IFN-
α, IFN-γ, IL-12 and IL-18 for the induction of Th1 type of immune responses in
DNA vaccination has recently been pointed out (Song et al., 2000; Cohen et al.,
1998; Gurunathan et al., 2000a; Gurunathan et al., 2000b; Kim et al., 1998). In
mice,  the  presence  of  IFN-α  was shown  to  be  essential  for  the  induction  of
antigen-specific Th1-associated IgG isotypes as well as for IFN-γ  production  by
spleen cells after immunization with a DNA vaccine against ADV (Tudor et al.,
2001). Also activation of B cells and CD8 positive T cells by the DNA vaccine
were shown to be dependent  on  the  presence  of  a  functional IFN-α  receptor  in
mice, which is in line with findings that CpG can induce upregulation of adhesion
and activation molecules in  an  IFN-α  dependent  manner  (Kranzer et al.,  2000;
Sun & Sprent, 2000; Sun et al., 1998).
The immunogenicity of DNA vaccines in mice and pigs can also be enhanced by
addition of cytokines and co-stimulatory molecules, in  the  form  of  recombinant
protein or expressed from a DNA plasmid (Song et al., 2000; Cohen et al., 1998;
Gurunathan et al.,  2000a;  Gurunathan et al.,  2000b;  Kim e t  a l . ,  1998).  The
ability  of  IL-12 to  promote  Th1  immune  responses  has  been  utilized  in  this
respect (Gurunathan et al., 2000a; Kim et al., 1998). For a DNA vaccine against
porcine  ADV,  co-administration  of  a  plasmid  encoding  GM-CSF  increased
antibody titers and resulted in faster clearance of virus at challenge (Somasundaram
et al., 1999; Dufour et al., 2000). In contrast,  the  immune  response  to  another
porcine ADV vaccine was not improved by plasmids expressing IFN-γ  or  IL-12
(van Rooij et al., 2002). The latter finding may be explained by the fact that, as
mentioned  above,  IL-12  alone  may  have  a  relatively  poor  immunostimulatory
effect that is strikingly increased by combination with IL-18. In fact, addition of
plasmids  encoding  IL-12  and  IL-18  in  DNA  vaccines  against  feline
immunodeficiency  virus  (Hanlon e t  a l . ,  2001)  and  against  Mycobacterium
tuberculosis  in  mice  (Triccas e t  a l . ,  2002)  favoured  a  Th1  type  of  immune
response and increased protection to challenge. Furthermore, combining an  ADV
vaccine vector with plasmids encoding IL-12 and IL-18 restored the Th1 response
in type I IFN receptor  deficient  mice  (Tudor et al.,  2001).  An  IL-6 expression
vector was also shown to enhance the efficacy of a DNA vaccine against influenza
virus in mice, but was without effect in pigs (Larsen & Olsen, 2002; Larsen et al.,
1998).23
Aims of the present study
The aims of the present study were to:
  Evaluate the  possible  adjuvant  effects  of  the  vaccine  plasmid  pDNA3,  by
studying the ability of the plasmid to induce production of cytokines in vivo.
  Study the expression in vivo of IL-6 and GM-CSF from pcDNA3 containing
cDNA for these cytokines.
  Construct the cDNA for a  porcine  IL-12  fusion  protein  in  pcDNA3  and  to
verify the expression of biologically active IL-12 in vitro.
  Characterize the IFN-γ producing cells after stimulation of porcine PBMC  by
IL-12 and IL-18.
  Achieve differentiation of porcine monocytes to DC using IL-4 and GM-CSF
in vitro and to study effects of IFN-α, TNF-α and pcDNA3 on the moDC.
  Evaluate the ability of moDC, differentiated with or without the presence of
IFN-α to produce cytokines at various stimuli.
  Study the  properties  of  ODNs  required  for  IFN-α  induction  in  cultures of
PBMC.
  Characterize  the  IPC  after  stimulation  of  PBMC  with  ODN,  pcDNA3  or
ADV, using flow cytometry and in situ hybridization.24
COMMENTS ON METHODS
Experimental animals and implantation of tissue chambers
The studies were performed using specific pathogen free (SPF)  pigs  (Landrace  x
Yorkshire; Serogrisen,  Ransta,  Sweden)  (Wallgren et al.,  1999;  Wallgren  &
Vallgårda, 1993) or conventionally reared Yorkshire pigs The SPF  pigs were pre-
selected for similar IFN-α producing capacity in vitro in response to the plasmid
pcDNA. In comparison to pigs housed under SPF  conditions, the conventionally
reared  pigs  may  have  different  health  status  that  might  complicate  the
interpretation of the immunological response. Other factors that  might  influence
e.g. the IFN-α response are for instance age and the breed of the animal (Nowacki
et al., 1993). The ability to produce IFN-α at certain stimuli has been shown to
vary  between  parental  offspring  groups  (Edfors-Lilja e t  a l . ,  1994).  Therefore,
PBMC from animals from different litters were used to avoid a bias towards high
or low IFN-α  response  to  various  stimuli  (papers  III  and  IV),  and  also  in  the
mixed leukocyte reactions (MLR; papers II and III) to avoid the use of SLA class
II matched individuals. The tissue chambers, implanted in the SPF pigs, consisted
of  silicone  rubber  tubes  (70  mm)  that  were perforated at  the  ends,  sealed  and
implanted subcutaneously close to regional lymph nodes (Wattrang et al., 1997).
Cytokine-expressing plasmid vectors
The cDNA for poIL-12 p35, p40 and a poIL-12 fusion protein  were cloned into
pcDNA3. For construction of the cDNA for the fusion protein, the open  reading
frames for poIL-12 p40 and p35 were PCR  amplified from plasmids encoding the
respective  cDNA,  but  omitting  the  p40  signal  peptide.  A  (Gly4Ser)3  linker
sequence (L) (Huston et al., 1988) was ligated between the p40 and p35 cDNAs,
and the whole cDNA cassette was then cloned into pcDNA3 (pcDNA/p40-L-p35)
and also into a pMT/V5-HisA plasmid. This latter construct encoded a porcine IL-
12 fusion protein (designated pMT/IL-12 fusion protein) with a polyhistidine (his)
tag at the C-terminus. The pcDNA3 constructs were transfected into COS cells and
the pMT/his-p40-L-p35 construct was  transfected into  Drosophila  melanogaster
Schneider 2 (S2) cells. The IL-12 biological activity in culture  supernatants was
determined  using  the  IL-12/IL-18  bioassay  (see  below).  The  histidine  tagged
pMT/IL-12 fusion  protein  was  purified  on  Ni-NTA  agarose  and  the  purity  and
concentration was estimated by SDS-PAGE.
In addition, the cDNA for poIL-6 was cloned into pcDNA3 (pcDNA3/IL-6) and
and the expression of bioactive IL-6 was confirmed by bioassay after transfection
of COS cells (paper I). This plasmid was subsequently used to immunize mice for
generation of  monoclonal  antibodies  (mAbs).  The  poGM-CSF  (pcDNA3/GM-
CSF) vector has been described before (Somasundaram et al., 1999). In paper III,
the cDNA for IFN-α1 was cloned in the pcDNA3 plasmid and expressed in COS
cells.25
Differentiation of monocytes to dendritic cells in vitro
Porcine monocytes were obtained by plastic adherence of PBMC and cultivated for
5 days in the presence of recombinant human GM-CSF (rhuGM-CSF) and rhuIL-
4.  Such  cells  obtained  a  dendritic morphology  and  were  defined  as  immature
monocyte-derived DC (moDC). The effect of poIFN-α on the differentiation was
also studied. The maturing effects of TNF-α and of the plasmid pcDNA3 on DC
were studied, and the stimulated DC were analyzed for upregulation of MHC class
II and B7 molecules as determined by flow cytometric analysis, and also for their
ability to induce allogeneic and  syngeneic MLR.  In  the  MLR,  the  proliferative
response of PBMC  to irradiated moDC from syngeneic or allogeneic donor  pigs
was measured using H
3-thymidine uptake.
In vitro induction of cytokines
The cytokine producing ability of stimulated porcine DC, was compared to that of
monocytes  or  fresh PBMC.  The  cytokine  induction  was  performed  using  the
expression plasmid pcDNA3. This plasmid has previously been shown to induce
IFN-α production by porcine PBMC (Magnusson et al., 2001a). Heat inactivated
A. pleuropneumoniae, which was known to induce production of IL-6 in pigs in
vitro and in vivo (Fossum et al., 1998; Johansson et al., 2001) and of IFN-α  in
vitro (Magnusson et al., 2001a; Johansson et al.,  2001;  Wattrang et al.,  1998)
was also used.
The  UV-inactivated  herpesvirus  Aujeszky’s  disease  virus  (ADV)  was  used
because of its documented IFN-α inducing ability on porcine cells (Artursson e t
al., 1995; Artursson et al., 1992), possibly in NIPC/PDC.  ADV is an enveloped
virus  containing  linear  dsDNA  that  may  cause  neurological  and  respiratory
disorders in the pig. In humans, the herpes simplex virus (HSV) induces IFN-α
production  exclusively by  NIPC/PDC,  while  both  NIPC/PDC  and  monocytes
respond to stimulation with Sendai virus (Magnusson et al.,  2001b;  Fitzgerald-
Bocarsly, 2002). Sendai virus, that is an enveloped paramyxovirus with a negative
stranded RNA genome, was therefore included in paper III.
Furthermore,  the  IFN-α  inducing  ability  of  various  ODN  was  studied  in
cultures of PBMC, with or without pre-treatment with lipofectin (paper IV). IFN-
α  producing cells  after stimulation  of  PBMC  with  the  ODN  2216,  ADV  or
pcDNA3 were characterized using flow cytometry and  in  situ  hybridization.  For
detection  of  IFN-γ  producing  cells  by  flow  cytometry,  porcine  PBMC  were
stimulated with rpoIL-12 and rhuIL-18 (paper II).
Immunoassay and bioassay
Cytokine production was measured using  bioassays  and  by  immunoassays.  The
bioassays measure the biological activity of the  protein,  but  the  results  may  be
affected by other components in serum or culture supernatants having  similar  or
counteracting effects as the protein measured. The immunoassays are more specific
because the protein is detected with antibodies, but nothing is then known about
its biological activity. Levels of IFN-α (papers I, III and IV) and IFN-γ (papers II
and III) were measured by two immunoassays based on the dissociation-enhanced26
lanthanide fluoroimmunoassay (DELFIA) principle as previously described, using
pairs of mAbs (Artursson et al., 1995; Wattrang et al., 1997). A laboratory IFN-α
standard obtained from Sendai virus induced porcine PBMC  was used (Diaz de
Arce et al., 1992), and the IFN-γ standard consisted of rpoIFN-γ expressed in E.
coli.
The levels of IL-6 were determined by a DELFIA (paper I) using a  polyclonal
goat  antibody  to  porcine  IL-6  and  a  biotinylated  anti-poIL-6  mAb  (LF159,
produced  in  our  laboratory)  combined  with  europium-labeled  streptavidin.  A
commercially available ELISA for IL-6 was also used. Furthermore, IL-6 activity
was detected by a bioassay (papers I and III) using B9 cells (Fossum et al., 1998),
using rpoIL-6 as standard.
Two bioassays were used for detection of GM-CSF (paper I), either measuring
effects on the human GM-CSF dependent TF1 cell-line, or proliferation of porcine
bone marrow cells (Somasundaram et al., 1999).
The IL-12/IL-18 bioassay (papers II and III) was based on the ability of IL-12 in
combination  with  rhuIL-18  to  induce  IFN-γ  production  by  PBMC  in  mixed
leukocyte cultures (MLC) established from two pigs. An anti-huIL-12 mAb, cross-
reacting with poIL-12 (Kokuho et al., 1999), was used to determine whether the
IFN-γ production was caused by IL-12.
Detection of cytokine mRNA by RT-PCR
To verify the results obtained by bioassay for IL-6  and  IL-12  (paper  III)  reverse
transcriptase  polymerase  chain  reactions  (RT-PCR)  were  applied  to  mRNA
purified  using  oligo-dT  coated  magnetic  beads  (Dynal,  Oslo,  Norway).  The
cytokine cDNA was amplified using the primer pairs described in Table 1 (paper
III). The primer recognized sequences that were, in comparison to the human IL-6
and IL-12 genes, most likely located on separate exons. To increase the sensitivity
and specificity of the RT-PCR for IL-12, nested PCR  was performed  using  the
full length PCR product as template and internal primers.
Analysis of IFN producing cells by flow cytometry
Flow cytometric methods were developed for the study of the IFN-α and  IFN-γ
producing cells (papers II and IV). Staining for intracellular IFN-γ was carried out
using  a  phycoerythrin  (PE)-conjugated  anti-poIFN-γ  mAb  on  cells  fixed  with
paraformaldehyde and permeabilized with saponin (paper II). The IFN-γ producing
cells were also analyzed for the presence of cell surface antigens by staining, before
fixation and permeabilization, using mAbs directed to CD3 (FITC-labelled), CD2
(biotinylated) and CD14 (unlabelled). The binding  of  the  latter two  mAbs  was
visualised  using  RPE-Cy5-labelled  streptavidin  (CD2) and  FITC-labelled  goat-
anti-mouse Ig (CD14).
Detection of  intracellular  IFN-α  was  performed  on  paraformaldehyde-fixed  cells
that were permeabilized with tween-20. A biotinylated anti-IFN-α  mAb was used
in combination with PE-labelled streptavidin (paper IV). It was important to block
unspecific binding, by using 5 % normal mouse serum in the case of staining for27
IFN-γ, or by using 5 µg/ml mouse IgG and 10 % of specific pathogen free (SPF)
pig sera when staining for IFN-α.
Detection of IFN-α α α α mRNA-containing cells by in situ
hybridization
To further characterize the IPC, a method to detect cells expressing IFN-α mRNA
by in situ hybridization  was established  (paper  IV).  Briefly,  stimulated  PBMC
were fixed in  paraformaldehyde  and  transferred to  glass  slides.  The  cells  were
hybridized with  a  biotinylated  cRNA probe,  prepared  by  in  vitro  transcription
from a 829 bp DNA for poIFN-α1 in pGEM in the presence of biotin-16-UTP and
T7-RNA polymerase or  Sp6-RNA  polymerase. After hybridization,  the  mRNA
positive  cells  were  detected  by  means  of  the  sensitive  GenPoint™  catalyzed
amplification  system,  using  a  primary  horseradish  peroxidase  (HRP)  labelled
streptavidin, biotinyl tyramide and  secondary  HRP-streptavidin.  The frequencies
of positive cells, and the intensity of labelling were estimated.
Statistical methods
When indicated, data are presented as mean values ± SEM of all  pigs  tested.  In
paper  III,  pairwise  comparisons  between  the  different  cell  types  for  each
stimulator:responder ratio in the MLR and calculation of p-values were performed
using Wilcoxon signed rank test. The Bonferroni-Holm method (Holm, 1979) was
used for adjustment for multiple testing.28
Results and discussion
The vector pcDNA3 induces production of IFN-α α α α  in vivo (paper
I)
DNA  vaccines  have  recently  been  shown  to  induce  a  protective  Th1-type  of
immune  response, including  antigen  specific  CTL  responses,  in  many  species
(Gurunathan et al., 2000b; Gurunathan et al., 2000a; Liu &  Ulmer,  2000).  The
immune response to vaccines may be biased towards a Th1 type  of  response by
using immunoregulatory cytokines as adjuvant, included as plasmids encoding the
cytokine cDNA (Song et al., 2000; Cohen et al., 1998; Gurunathan et al., 2000a;
Gurunathan et al., 2000b; Kim et al., 1998). Furthermore, it has been shown that
vectors  used  in  DNA  vaccination,  by  the  presence  of  CpG  motifs,  may  have
adjuvant  effects (Klinman et al.,  2000).  In  porcine PBMC,  the  ability  of  the
vaccine vector pcDNA3, but not  the  methylated  form  of  the  plasmid  to  induce
production of IFN-α and IL-6 had earlier been described (Johansson et al., 2001;
Magnusson et al., 2001a). To study if the same immunostimulatory effect could
be achieved in vivo, SPF  pigs were injected with pcDNA3, the methylated form
of the plasmid and plasmids encoding the cDNA for IL-6 (pcDNA3/IL-6) or GM-
CSF  (pcDNA3/GM-CSF). The plasmids  were  injected  into  subcutaneous tissue
chambers,  located  close  to  the  lymph  nodes  of  pigs  as  previously  described
(Wattrang et al., 1997).
The plasmid pcDNA3 (with or without the addition of cytokine cDNA) had an
immunostimulatory effect in pigs as demonstrated by a local production of IFN-α
in tissue culture fluid (TCF) (Fig. 1 and 2), while no IFN-α could be detected in
serum.  Methylation  of  pcDNA3  abolished  the  IFN-α  inducing  capacity  of  the
plasmid. The IFN-α response was higher after the second injection with plasmid,
which could be explained by recruitment of IPC to the injection site. Furthermore,
the locally produced IFN-α at the first injection may also have a priming effect on
the IPCs (see Introduction), resulting in enhanced IFN-α production at the second
injection in the same tissue chamber. The kinetics of the IFN-α response in vivo
was similar to that induced by e.g. ADV in vitro (Wattrang et al., 1995) and in
vivo (Wattrang et al., 1997; Artursson et al.,  1995).  The plasmid  pcDNA3  had
earlier been shown to require preincubation with lipofectin for induction of IFN-α
in vitro (Magnusson et al., 2001a), whereas induction with the dsRNA analogue
poly(I):poly(C) in vivo (Wattrang et al.,  1997)  or  with  pcDNA3  in  the  present
study did not. The mechanisms for uptake of the plasmid pcDNA therefore seem
to differ in vivo and in vitro. Lipofectin may facilitate the cellular uptake  of  the
plasmid and protect against degradation  by  nucleases  (Pisetsky  &  Reich,  1999;
Thierry & Dritschilo, 1992; Bennett et al., 1992; Hartmann et al., 1998). Thus,
the levels of IFN-α induced could be affected by insufficient uptake of the plasmid
into the cells, by degradation of the plasmid and also depend on which cell type is
transfected.
No  production  of  IL-6 was detected that  clearly was induced by  the  various
plasmids, because injection with saline induced similar levels of IL-6 in the TCF
(Fig.  3).  The increased levels  of  IL-6  were  most  likely  due  to  the  sampling29
procedure, and for instance elicited  by  endothelial  injury  (Krishnaswamy et al.,
1999).  The  presence  of  IL-6  in  serum  was  detected  48h  after  injection  with
pcDNA3/IL-6  and  12h  after injection  with  pcDNA3  using  bioassay,  but  these
results were not confirmed by immunoassay. However, a local production of IL-6
was detected in the lungs after instillation of plasmid DNA in mice (Yew et al.,
1999).  Furthermore,  injection  of  plasmid  DNA  or  CpG  ODN  induced  IL-6
responses in lung lavage fluid or serum (Schwartz et al., 1999; Yi et al., 1996).
Expression  of  plasmid-encoded  IL-6  has  been  detected  in  murine  sera  after
intradermal  injection  of  a  plasmid  encoding  this  cytokine  (Sun e t  a l . ,  1995;
Larsen et al., 1998), and the expressed IL-6 enhanced the effect of influenza DNA
vaccination (Larsen et al., 1998).
In the present study, the expression of  GM-CSF  by  pcDNA3/GM-CSF  could
not be detected in  TCF  or  serum by  available bioassays.  The failure to  detect
plasmid-encoded cytokines may be due to that the plasmids were not expressed in
the tissue chambers or at levels below detection. In mice, plasmid-encoded  GM-
CSF  was shown to attract antigen-presenting cells to the site  of  injection.  Both
mature (Kusakabe et al., 2000) and immature (Haddad et al., 2000) DC have been
detected in  the  muscle  after  intramuscular injection  of  plasmids  encoding GM-
CSF and the immature DC migrated further to the local draining lymph node. The
pcDNA3/GM-CSF  construct used  in  the  present study  has  in  previous vaccine
studies improved the protective effect at DNA  vaccination  of  pigs  against  ADV
(Dufour et al., 2000; Somasundaram et al., 1999), which indicates that GM-CSF
actually can be expressed by the plasmid cDNA in vivo.
Injection with  pcDNA3/GM-CSF  did  not  affect the  numbers  of  mononuclear
leukocytes and neutrophilic granulocytes in the  TCF  (Fig.  4).  Increased cellular
influx of neutrophils was detected after injection of plasmid as well as saline (Fig.
4)  and  probably reflects  a  post-operative  effect  that  enhanced  the  inflammatory
response to the injections in general.
The adjuvant effects of pcDNA3 have been studied in mice immunized with  a
DNA  vaccine  against  ADV,  and  co-delivery of  pcDNA3  enhanced  the  antigen-
specific  antibody  response  in  both  wild-type  (WT)  and  IFNAR-deficient  mice
(Tudor et al., 2001). The DNA vaccine induced a Th1 type of immune response in
WT mice, with high IgG2a:IgG1 ratio and IFN-γ production by spleen cells after
restimulation in vitro, but  not  in  the  IFNAR  deficient mice.  This  indicates an
importance  for  IFN-α  in  the  generation  of  Th1  immune  responses  at  DNA
vaccination. Furthermore, a role for IFN-α was shown for the activation of CD8+
T  cells  and  B  cells.  When  testing  plasmids  expressing  IL-12  and  IL-18  as
adjuvant, the Th1 responses was strongly increased also in IFNAR deficient mice.
In conclusion, the  use  of  tissue  chambers  provides  means to  study  the  local
immunostimulatory effects of plasmid DNA in vivo in the pig. The model could
also be used to estimate side effects induced by vaccine adjuvants, such as  local
inflammatory  responses.  Efficient in  vivo  induction  of  IFN-α  by  pcDNA3  and
other vaccine vectors could be an important goal when DNA vaccines are designed,
because IFN-α  has  an  impact  on  the  early innate  immunity  as  well  as  on  the
generation and maintenance of the specific immune response (see Introduction).30
Construction and in vitro evaluation of porcine IL-12 vectors
(paper II)
Cytokines  expressed  by  vaccine  plasmids  have  been  shown  to  have  adjuvant
effects in DNA vaccination (Song et al., 2000; Kim et al., 1997; Gurunathan et
al., 2000a).  Co-administration  of  plasmids  expressing vaccine  antigen  and  e.g.
plasmids encoding IL-12 or IFN-γ resulted in protective  antigen-specific  cellular
immune responses in mice (Kim et al., 1998; Song et al., 2000). The ability of
IL-12 to direct the immune response to development of antigen specific Th1 cells
and CTL indicates that IL-12 can be an important adjuvant in DNA vaccination,
also in the pig. We therefore constructed pcDNA3 plasmids encoding  the  cDNA
for IL-12 p35 and p40 subunits, and also for a fusion protein of porcine IL-12.
It is essential to be able to evaluate the biological activity of poIL-12 expressed
by plasmids. We therefore developed a bioassay, the IL-12/IL-18 bioassay, based
on the ability of IL-12 to induce IFN-γ production in porcine PBMC.  We found
that  huIL-12  induced  a  dose  dependent  production  of  poIFN-γ  in  PBMC,
especially in MLC cultures (Fig. 1a). This production was strongly enhanced in a
dose dependent fashion by rhuIL-18,  but  the  rhuIL-18  alone  was  a  poor  IFN-γ
inducer. In a similar manner, IL-12 enhanced the IFN-γ inducing activity of rhuIL-
18. Such synergistic effects of IL-12 and IL-18 have previously been described in
human and murine systems (Tominaga et al., 2000), and are probably related to
the ability of IL-18 to up-regulate the IL-12Rβ2 (Chang et al., 2000) and of IL-12
to  increase  the  IL-18Rβ  expression  (Yoshimoto e t  a l . ,  1998).  Furthermore,
binding  of  IL-18  to  the  IL-18  receptor  activates  IL-1  receptor-associated  kinase
(IRAK), leading to activation of nuclear factor κB (NFκB). IL-12, when binding
to the IL-12 receptor, activates STAT3 and 4 to induce gene transcription in Th1
cells.  This  may  therefore also  explain  why  IL-12  and  IL-18  synergize  in  the
induction of IFN-γ, because both NFκB and STAT4 are known to be transcription
factors for the IFN-γ gene (Okamura et al., 1998; Nakanishi et al., 2001).
Porcine IL-12 was expressed by  co-transfecting COS  cells  with  two  pcDNA3
plasmids containing IL-12 p40 and p35, respectively. Such poIL-12 heterodimers
were able to induce IFN-γ in the IL-12/IL-18 bioassay (Fig. 2). No activity was
induced  after  transfection  of  the  plasmids  separately.  This  indicates  that  a
functional heterodimer of p40 and p35 was necessary for biological activity, which
is in agreement with earlier studies of poIL-12 (Foss & Murtaugh, 1999; Kokuho
et al., 1999)
A  fusion  protein  of  porcine IL-12 was also  constructed,  containing  the  p40
domain  followed by  a  linker  and  the  p35  domain  (pcDNA3/p40-L-p35).  This
plasmid expressed a protein in transfected COS cells that was highly active in the
IL-12/IL-18 bioassay (Fig. 3), indicating that the linker sequence does not interfere
with the functionally relevant folding of the poIL-12 subunits.
The cDNA for the IL-12 fusion protein was also transferred to the plasmid pMT-
His (pMT/His-p40-L-p35), and transfected Drosophila melanogaster Schneider  2
cells (S2 cells) showed both transient and a stable expression of biologically active31
poIL-12 as determined by  the  IL-12/IL-18  bioassay  (Fig.  4).  A  relatively  good
expression was obtained in the Drosophila S2 cells, about 10 µg per ml medium.
The His-tagged  poIL-12  fusion  protein  was  purifed  using  Ni-NTA agarose  and
analysed by SDS-PAGE and Western blotting (Fig. 5). The purification resulted
in a pure and biologically active poIL-12, but the yield was low (5-10%).
The  poIL-12  fusion  protein  should  be  valuable  as  research  reagent  and  as
adjuvant. The in vivo bioactivity of a similar  poIL-12  p40-L-p35  fusion  protein
has  recently  been  demonstrated  in  a  cholera  toxin  vaccination  model  in  swine
(Foss et al., 1999). Because of the documented adjuvant effects of IL-12 (Kim et
al., 1998; Gurunathan et al.,  2000a),  the  pcDNA3/p40-L-p35  expression vector
could be evaluated as adjuvant to enhance the immune response to DNA vaccines
in  pigs.  Recently,  a  plasmid  capable  of  expressing  poIL-12  heterodimers  was
tested  in  pigs  and  found  to  have  poor  activity  as  adjuvant  in  a  DNA  vaccine
against ADV (van Rooij et al., 2002). Because of the pronounced synergy between
IL-12  and  IL-18  in  the  pig  observed  in  the  present  study,  combinations  of
plasmids  expressing  poIL-12  and  poIL-18  should  therefore  be  evaluated  as
adjuvant in DNA vaccines. A further motivation for using the combination poIL-
12  and  poIL-18 is  the  low  biologic  activity  of  poIL-12  on  activated  porcine
lymphocytes, which may be due to a  low  expression of  the  IL-12Rβ2  (Solano-
Aguilar et al., 2002).
Phenotype of the IFN-γ γ γ γ producing cells induced by IL-12 and IL-
18 (paper II)
Many different cell types, such as NK cells, T cells, macrophages and DC, have
the  ability  to  produce  IFN-γ  in  mice  and  humans  (Okamura e t  a l . ,  1998;
Tominaga et al., 2000; Nakanishi et al.,  2001;  Otani e t  al.,  1999),  and  at  the
initiation of this study it was not known which cells produce IFN-γ in the pig. In
paper II it was demonstrated that the combination of IL-12 and IL-18 was a potent
inducer of IFN-γ production in poPBMC. The cell types responsible for this IFN-
γ production were identified, and for this purpose we established  a  three colour
flow cytometry method involving staining for intracellular IFN-γ and cell-surface
antigens.
When  poPBMC  in  MLC  were  stimulated  by  poIL-12  and  huIL-18,
approximately 3.0% of the cells were stained for intracellular IFN-γ. Staining for
the surface antigens CD2, CD3 and for intracellular IFN-γ revealed that the IFN-γ
containing  cells  were mainly  CD2+CD3+  T  cells  (69%)  and  CD2+CD3-  cells
(31%) (Fig. 6). The latter cells are considered to be NK cells (Summerfield et al.,
2001;  Yang &  Parkhouse,  1996).  The  CD2-CD3+  T  cells,  which  constituted
about 50% of the  CD3+  cells  completely  failed to  produce  IFN-γ.  These  cells
should to a large extent be CD4-CD8- TCRγδ+ cells, which have been identified
in high  frequency  in  young  pigs  (Yang  &  Parkhouse,  1996).  Furthermore, the
IFN-γ producing cells did not express CD14. This antigen is present on porcine
monocytes and myeloid DC (Carrasco et al., 2001). It was recently demonstrated
by a similar flow  cytometric method  and  polyclonal  activation  of PBMC,  that
approximately half of the T cells that produced IFN-γ were γδ T cells in pigs of
the same age as the pigs in the present study (Rodriguez-Carreno et al., 2002).32
Although the exact identity of the IFN-γ  producing cells  in  the  pig  must  be
further evaluated, our findings that T cells and NK cells are the major  producers
agree with results obtained in other species (Okamura et al., 1998;  Tominaga e t
al., 2000; Nakanishi et al., 2001; Otani et al., 1999).
Characterization of monocyte-derived DC according to their
cytokine profile (paper III)
The DC have an important role in the defence against infection by their ability to
take up, process and present antigens, and their ability to stimulate  and  regulate
the adaptive immune response, e.g. by production of cytokines (see Introduction).
The DC are therefore also the most important target cell for antigen expression and
presentation in vaccination. Human  monocytes  have  been  differentiated  in  vitro
into moDC in the presence of GM-CSF and IL-4 (Hart, 1997). Further maturation
of  human  moDC  in  vitro,  with  consequent  upregulation of  co-stimulatory  and
MHC  class  II  molecules  and  enhanced  antigen-  presenting  capacity  has  been
induced by the use of the cytokines TNF-α and IFN-α (Shortman & Liu, 2002;
Luft et al., 2002) and by PAMPs such as LPS or CpG-ODN (Kadowaki & Liu,
2002; Shortman & Liu, 2002).
In  paper  III,  a  method  was  established  to  differentiate  porcine  adherent
monocytes to moDC in vitro in cultures with huIL-4 and huGM-CSF. The effects
of IFN-α during differentiation were studied. The maturing effects of TNF-α and
pcDNA3  were  determined  as  e.g.  the  enhanced  ability  of  the  DC  to  stimulate
proliferation of PBMC in an MLR. Furthermore, moDC cultured with or without
IFN-α  during  the  differentiation  were  characterized  according  to  their  ability
produce  cytokines  at  exposure  to  pcDNA3,  ADV,  Sendai  virus  or  A.
pleuropneumoniae.
The adherent monocytes obtained a dendritic morphology during differentiation
in huGM-CSF and huIL-4 (Fig. 1). No clear effect of IFN-α during differentiation
was  observed  on  the  cell  morphology.  Expression  of  MHC  class  II  and  B7
(CD80/CD86)  molecules  was  high,  regardless  of  whether  the  moDC  were
differentiated in the presence of IFN-α or not. That porcine monocytes exposed to
GM-CSF and IL-4 acquired antigenic and morphologic characteristics of myeloid
DC is in accordance with recently published studies (Carrasco et al., 2001; Paillot
et al., 2001).
The moDC could stimulate proliferation of allogeneic PBMC  and the presence
of  IFN-α  during  differentiation  increased  their  ability  to  stimulate  cell
proliferation  (Fig.  2a).  Such  effects  of  IFN-α  has  also  has  been  observed  for
human moDC (Santini et al., 2000; Radvanyi et al., 1999; Paquette et al., 1998).
Similar  results  were  obtained  when  the  DC  were  tested  in  syngeneic  MLR.
Interestingly,  it  has  recently  been  shown  that  the  proliferation  induced  in
syngeneic MLR is a response to autologous apoptotic material processed by  DC
(Chernysheva et al., 2002).
No enhancing effects of TNF-α could be observed on the ability of  moDC  to
stimulate an allogeneic MLR (Fig. 3a), which is in contrast to results obtained by33
others  with  porcine  moDC  differentiated  in  poGM-CSF  and  poIL-4,  where
addition  of  TNF-α,  TGF-β1  or  LPS  increased  the  allogeneic  MLR  response
(Carrasco et al.,  2001;  Paillot e t  al.,  2001).  Also  human  moDC  displayed  a
strongly  increased ability  to  stimulate  allogeneic  MLR  after  stimulation  with
TNF-α (Yang et al., 1999).
Furthermore, stimulation  of  the  moDC  with  pcDNA3  did  not  increase  their
capacity to evoke an allogeneic MLR (Fig. 3b). Our results are in contrast to those
of  one  study  where  plasmid  DNA  increased  the  ability  of  human  moDC  to
stimulate an MLR (Schattenberg et al., 2000). Other studies show, however, that
NIPC/PDC, but not moDC respond to induction by CpG-ODN (Schattenberg e t
al.,  2000;  Kadowaki  &  Liu,  2002;  Fitzgerald-Bocarsly, 2002).  The  discrepant
results may be explained by the fact that TLR9 is expressed by plasmacytoid DC,
but not by myeloid DC (Kadowaki & Liu, 2002; Hornung et al., 2002), and that
the plasmid DNA stimulate NIPC/PDC to produce cytokines such as IFN-α that
cause maturation of the moDC.
The moDC, or moDC differentiated in the presence of IFN-α, were compared to
PBMC  and adherent  monocytes  for their  ability  to  produce  the  Th1  associated
cytokines IL-12 and IFN-α and the Th2 cytokines IL-6 and  IL-10 (Table  2  and
Fig.  5). The plasmid pcDNA3 and Sendai virus induced production  of  IL-12 in
PBMC,  adherent monocytes and DC. However,  the  plasmid  pcDNA3  was  only
active  when  preincubated  with  lipofectin.  A.  pleuropneumoniae  induced  IL-12
only in the DC, while ADV failed to stimulate IL-12 production  in  these cells.
The induction of IL-12 bioactivity was confirmed by detection of p40 mRNA in
DC stimulated by A. pleuropneumoniae or by pcDNA3 using RT-PCR (Fig. 4).
A  constitutive  expression  of  p35  was  observed,  which  had  previously  been
described in mice (Bost & Clements, 1995), humans (Cassatella et al., 1995) and
pigs  (Foss  &  Murtaugh,  1997).  Interestingly,  RT-PCR  for  IL-12p35  after
stimulation with A. pleuropneumoniae revealed an additional larger PCR-product,
which contained an additional 75 bp that  were homologous  to  the  entire fourth
intron  of  the  human  p35  gene  (the  sequence  of  the  poIL-12p35  gene  was  not
available). This longer transcript may be explained by alternative splicing of this
intron  at  stimulation  with  A.  pleuropneumoniae.  The  relevance  of  these
preliminary data requires further study. However, it was reported that  differential
splicing of the murine p35 transcripts occurred when spleen cells were stimulated
with LPS or a combination of IFN-γ and CD40 (Hayes et al., 1998). Also from
the  human  p35  gene,  different  transcripts  from  IFN-γ  and  LPS  stimulated
monocytes  or  unstimulated  lymphoblastoid  cells  have  been  reported,  due  to
expression from different promoters (Vaidyanathan et al., 2001).
The plasmid pcDNA3, when preincubated with lipofectin,  and  the  herpesvirus
ADV induced IFN-α production in PBMC  but  not  in  moDC  or  monocytes.  In
contrast, Sendai virus induced IFN-α production in PBMC,  monocytes and  was
the only inducer of IFN-α production in moDC. Thus, the viruses tested induced
IFN-α  production  in  different  cell  types.  Also  human  monocytes  and  moDC
produce  IFN-α  at  induction  with  Sendai  virus,  while  only  the  NIPC/PDC
produces IFN-α at stimulation with herpesvirus, such as HSV (Fitzgerald 2002).
In the pig, a cell population with several characteristics  of  NIPC/PDC  has  been34
described (Nowacki &  Charley,  1993;  Nowacki et al.,  1993).  It  remains to  be
determined if the porcine NIPC/PDC are responsible for the IFN-α production at
exposure to plasmid DNA or ADV observed in the present study.
The  moDC  were  also  able  to  produce  Th2  associated  cytokines.  The  A.
pleuropneumoniae, and to a lesser degree also Sendai virus, induced production of
both IL-6 and IL-10. The ability of moDC to produce IL-6 at stimulation with A.
pleuropneumoniae was confirmed by determination of  IL-6  mRNA  by  RT-PCR
(Fig. 4). Also monocytes and PBMC  produced IL-6 and IL-10,  especially when
exposed to A.  pleuropneumoniae. Production  of  IL-6 and  IL-10,  has  also  been
demonstrated in human moDC (Salio et al., 1999; Reid et al., 2000), and may be
one way for microorganisms to  inhibit  cell-mediated  immunity  by  skewing  the
response  towards  the  Th2  pathway.  For  instance,  IL-10  has  potent  inhibitory
effects on the production of Th1 cytokines, such as IL-12 and IFN-α (D'Andrea et
al., 1993; Fickenscher et al., 2002; Payvandi et al., 1998).
The in vitro differentiated moDC were thus capable of producing both Th1 and
Th2 associated cytokines at appropriate stimuli. In general, no clear effect of IFN-
α during DC differentiation was observed on the cytokine production. The ability
of  porcine  moDC  to  induce  T  cells  producing  IFN-γ  and  IL-4  has  been
demonstrated in one study (Carrasco et al., 2001), and by their production of Th1
and Th2 associated cytokines, the moDC should be able to polarize this Th  cell
development. The porcine moDC generated in vitro therefore can be used for basic
studies of immune responses to  porcine vaccines.  The ability  of  the  monocyte-
derived porcine DC to produce high amounts of IL-12, and to produce IFN-α at
stimulation  by  Sendai  virus,  but  not  ADV,  indicates  that  the  porcine  moDC
resemble the human myeloid DC. Pig models could therefore be relevant also in
human vaccine research.
Induction of IFN-α α α α by CpG-ODN in infrequent porcine PBMC
(paper IV)
As discussed above, the human NIPC/PDC are the major producers of IFN-α in
response to CpG ODN and HSV (Fitzgerald-Bocarsly, 2002). A rare population of
IPC,  resembling  the  human  NIPC/PDC,  has  also  been  described  in  the  pig,
producing IFN-α in response to the herpesvirus ADV (Artursson et al., 1995), and
TGEV (Nowacki et al., 1993; Nowacki & Charley, 1993; Riffault e t  al.,  1997;
Riffault et al., 2001). The results presented in paper III indicated that cells present
among PBMC,  but not monocytes or moDC, did produce IFN-α in response to
the plasmid pcDNA3. It was therefore of interest, in paper IV, to study the ability
of PBMC to produce IFN-α at exposure to the plasmid pcDNA3 as well different
defined ODNs with unmethylated CpGs (Table I). We also characterized the IPC
by flow cytometric analysis and by in situ hybridization.
Initially,  the  IFN-α  inducing  capacity  of  phophodiester  ODN  H-I,  that
previously had been shown to induce IFN-α in human PBMC  (Magnusson et al.,
2001b), was estimated (Figs. 1a and b). The levels of IFN-α induced  by  ODNs
were comparable to,  or  higher than  those  induced by  the  plasmid  pcDNA3,  A.
pleuropneumoniae or ADV (Fig. 1c). The induction of IFN-α by pcDNA3 and the35
phosphodiester ODNs required preincubation of the ODN with lipofectin, which is
in accordance with earlier studies (Magnusson et al., 2001b). Also the activity of
A. pleuropneumoniae was increased by preincubation with lipofectin (Wattrang et
al., 1998) (Johansson et al., 2001; Magnusson et al., 2001a).
By modifying the  ODN  H  and  the  complementary  ODN  I  (Table  1),  it  was
shown that the induction of IFN-α in poPBMC was dependent on presence of a
central unmethylated CpG (Fig. 2). Thus, inversion of the CpG,  substitution  of
either the  bases C  or  G,  or  methylation  of  the  cytosine  in  the  CpG,  strongly
inhibited the IFN-α production by these ODNs. In contrast, similar alterations of
ODNs H and I did not consistently have the same effect on their ability to cause
IFN-α production in human PBMC (Magnusson et al., 2001b), indicating species
differences  in  the  mechanism for IFN-α  induction  by  ODNs.  Furthermore, the
concentration of ODN and lipofectin was different in these two studies, which also
may contribute to the discrepancies.
Inversion of the CpG in ODN A2 also resulted in a strong reduction of the IFN-
α production in the present study, while both ODNs A2 and A2
GC enhanced the
antigen specific antibody production and cell proliferation in pigs (Van der Stede
et  al.,  2002).  However,  injection  of  ODN  A2  completely  protected  mice  to
challenge with Listeria monocytogenes whereas those injected with A2
GC were not
protected (Klinman et al., 1999). Thus the importance of CpG  motifs  might  be
different in vitro and in vivo and seems to vary between species.
The  effects  of  the  chemical  composition  of  the  ODN  backbone  for  IFN-α
inducing  capacity  was  then  evaluated  using  ODNs  having  either  a  backbone
consisting  of  central  phosphodiester  nucleotides  (including  the  CpG)  and
phosphorothioate  nucleotides in  the  ends  (thioate/diester  ODNs)  or  a  complete
phosphodiester backbone. It was found that the thioate/diester ODNs (ODN 2216
and  D19)  induced  somewhat  higher  levels  of  IFN-α  than  ODNs  with
phosphodiester backbone (Fig. 3). These ODNs did not require lipofectin for the
induction  of  IFN-α.  Thus,  the  backbone  composition  did  only  moderately
influence the IFN-α inducing capacity of these ODN.
One major difference between the ODNs 2216, D19 and MM1  from  ODNs H
and I and A2 was the presence  of  poly-G  sequences  in  the  ends  of  the  former.
ODNs with poly-G sequences may form  quartenary  structures  that  enhance  their
uptake by cells, possibly by binding to scavenger receptors (Pearson et al., 1993;
Kimura e t  a l . ,  1994;  Lee e t  a l . ,  2000).  This  may  explain  why  the  ODNs
containing  poly-G  sequences  were  able  to  induce  IFN-α  without  the  help  of
lipofectin to enter the cells. However, addition of poly-G sequences to the ODN H
(Table  1)  increased  its  IFN-α  inducing  capacity  when  lipofected,  but  did  not
obviate the need for lipofectin (Fig. 4).
Studies on the IFN-α induction by ODNs in human PBMC  have revealed that
e.g. ODN 2216 exclusively induces IFN-α  production  in  NIPC/PDC  (Bauer e t
al.,  2001a;  Krug et al.,  2001a).  In  the  present  study,  the  estimation  of  the
frequency of porcine IFN-α producing cells,  by  staining  for intracellular  IFN-α
and subsequent flow cytometric analyses, revealed that between 0.03 to 0.07% of
the PBMC  produced  IFN-α  at  stimulation  with  ADV,  lipofected  pcDNA3  and36
ODN 2216 (with or without  lipofectin).  The light  scatter characteristics  of  IPC
stimulated by the various inducers  were  similar,  and  they  were  relatively  small
cells with low granularity. The validity of the  flow  cytometric determination of
IPCs was verified by detection of IFN-α mRNA containing cells among PBMC
using in situ hybridization. By their presence at a low frequency, and their light
scatter  characteristics,  the  IFN-α  producing cells  detected in  the  present  study
resembled the  NIPC/PDC  previously  described  in  humans  (Fitzgerald-Bocarsly,
2002)  and  also  in  pigs  (Nowacki e t  a l . ,  1993;  Nowacki  &  Charley,  1993).
Attempts  to  further analyse  these  IPC  by  staining  with  mAbs  to  cell  surface
markers are currently undertaken.
The role of  CpG-containing  ODNs  as  adjuvant  and  immuno-modulators  in
vaccination has been described in mice and primates and recently also in veterinary
animals such as cattle (Pontarollo et al., 2002b; Rankin et al., 2002) and pig (Van
der  Stede e t  a l . ,  2002).  The  present  study  shows  that  ODNs  with  poly-G
sequences have high IFN-α  inducing  capacity  and  such  ODNs may  be  used  to
increase the immunostimulatory effects of vaccines designed for pigs. The results
also indicate that immunostimulatory DNA containing unmethylated CpG, either
as  plasmid  DNA  or  defined  ODNs,  can  activate  IFN-α  production  in  porcine
leucokytes  that  resemble  the  human  NIPC/PDC.  The finding  that  ODNs  with
poly-G sequences were strongly IFN-α inducing, even in the absence of lipofectin,
may  be  explained  by  improved  uptake  of  DNA  by  the  IPC.  Therefore,  an
engineered  increased  uptake  of  vaccine  plasmids  may  result  in  both  increased
vaccine antigen production and adjuvant action.37
General summary and conclusions
The most important aim of these studies was to study the adjuvant properties of
unmethylated CpG-containing DNA, such  as  vaccine  plasmids  and  CpG-ODNs,
especially the ability to induce immunoregulatory cytokines in the pig. The cells
producing such cytokines were also studied. The possibility to further enhance the
effects  of  DNA  vaccines,  e.g.  by  addition  of  plasmids  expressing
immunostimulatory cytokines also received some attention.
The main results were the following:
  The vaccine plasmid pcDNA3 was shown to induce a local IFN-α production
in vivo, when injected into subcutaneously implanted tissue chambers in pigs.
The IFN-α production was detected within 8 to 24 h, was dependent on the
presence of unmethylated CpG-dinucleotides in the plasmid and was achieved
in the absence of lipofectin. However, the expression of GM-CSF or IL-6 after
injection with  pcDNA3  plasmids  containing  the  cDNA  for  these  cytokines
could not be verified. Still,  the cytokines may have been expressed at levels
below detection or produced by DC, or other cells,  that  had  migrated away
from the tissue chambers, especially to the local lymph node.
  The  adjuvant  effect  of  DNA  vaccines  can  be  further  enhanced  by  co-
administration of plasmids expressing immunoregulatory cytokines. For such
purpose, the cDNA for  a  porcine  IL-12  fusion  protein was  constructed  and
inserted into pcDNA3, and the expression of biologically active IL-12 protein
was verified in COS  cells.  The fusion  protein  was biologically  active also
after expression in  Drosophila  (S2)  cells  and  subsequent  purification.  The
ability of IL-12 to induce IFN-γ production in poPBMC  was synergistically
enhanced by huIL-18, an effect that earlier had been shown in other species.
The results suggest that combinations of plasmids expressing IL-12 and IL-18
should have enhanced adjuvant effects on DNA  vaccines.  Furthermore,  flow
cytometric analyses after  intracellular  staining  of  poPBMC  stimulated  with
IL-12/IL-18 showed that the cells producing IFN-γ were mainly T cells  and
NK cells.
  It was of importance to study the effect of e.g. immunostimulatory DNA on
moDC because these cells are major targets in vaccination. Therefore, porcine
moDC were differentiated from adherent blood monocytes in vitro with IL-4
and GM-CSF.  A  possible  role of  IFN-α  in  promoting  maturation  of  the
immature moDC to highly antigen presenting moDC was also demonstrated,
confirming  previous  results  with  human  moDC,  differentiated  in  a  similar
way. The porcine moDC responded to Sendai virus, A. pleuropneumoniae and
lipofected  pcDNA3  with  production  of  IL-12  and  to  Sendai  virus  with
production of IFN-α. It is notable that the moDC did not produce IFN-α in
response to CpG-DNA in form of the plasmid pcDNA3 or to the herpesvirus
ADV. The moDC were also able to produce the Th2 associated cytokines IL-6
and IL-10 at stimulation  with  A.  pleuropneumoniae  and  Sendai  virus.  The38
cytokine production by the moDC was thus highly dependent on which type
of inducer the cells were exposed to.
  The  previous  results  revealed  that  the  plasmid  pcDNA3  induced  IFN-α
production in PBMC, but not in the moDC. The characteristics of the CpG-
DNA, in the form of ODNs, contributing to  the  IFN-α  production  and  the
cells involved were studied. The ability of ODN to induce IFN-α production
in poPBMC was dependent on  a  central  unmethylated  CpG.  It  was shown
that the phosphodiester ODNs H and I required preincubation in lipofectin for
IFN-α induction, like the  plasmid  pcDNA3. In  contrast,  the  thioate/diester
ODNs with poly-G sequences in the ends, and the corresponding ODNs with
complete diester backbone, were potent inducers of IFN-α, also in the absence
of  lipofectin.  Thus,  the  backbone  composition  had  no  major  effect on  the
IFN-α  inducing  capacity  of  ODNs.  The  ability  to  induce  IFN-α
independently  of  lipofectin  may  be  due  to  the  poly-G  sequences,  that  are
known to facilitate the uptake of ODNs by cells.  The presence  of  a  poly-G
sequence  was  also  shown  to  enhance  the  IFN-α  inducing  ability  of  the
phosphodiester ODN H, but could not in this  case  circumvent  the need  for
lipofectin.
  Among  human  PBMC,  the  thioate/diester  ODN  2216  (with  poly-G
sequences) is known to induce IFN-α production exclusively in NIPC/PDC.
The porcine IPC induced by CpG-DNA in the form of lipofected pcDNA3 and
2216 were therefore characterized by flow cytometry and in situ hybridization.
The IPC  were present at  a  low  frequency  (less  than  0.1  %),  had  a  high
labelling intensity and had the light scatter typical for small  cells  with  low
granularity. In this way the porcine IPC resemble the human NIPC/PDC.
The findings in the present thesis indicate similarities between subtypes of DC in
porcine  and  human  blood,  especially  in  their  ability  to  produce  the  key
immunoregulatory  cytokines  IL-12 and  IFN-α  in  response  to  CpG-DNA.  The
results will furthermore facilitate development of  improved  adjuvants  for  use  in
porcine vaccines, and also suggest that the pig may be a relevant model for human
vaccine research.39
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